---
title: Can I share a recommendation or comment regarding clinical information about RxVigilance?
description: The pharmacy and technology professionals who develop RxVigilance are always open to receiving feedback, comments and suggestions from users.
---
[Skip to content](https://faq.vigilance.ca/en/rxvigilance-user-comments#main-content)
- [English](https://faq.vigilance.ca/en/rxvigilance-user-comments)
- [Français](https://faq.vigilance.ca/fr/rxvigilance-commentaires-utilisateurs)
English
Show submenu for translations
[Can't find the answer you're looking for? Write to us.](https://faq.vigilance.ca/en/kb-tickets/new)
![loog-blanc.png\]](https://faq.vigilance.ca/hs-fs/hubfs/loog-blanc.png?height=42&name=loog-blanc.png)
- [Blog](https://www.vigilance.ca/contact-us#formulaire)
- [Press releases](https://www.vigilance.ca/press-releases?_gl=1*k5efc9*_gcl_au*NTkwNDU5NTIzLjE3MzY0MzY2NTI.)
- [Vigilance.ca](https://www.vigilance.ca/home?_gl=1*1iopex7*_gcl_au*NTkwNDU5NTIzLjE3MzY0MzY2NTI.)
- [RxVigilance News](https://www.vigilance.ca/news?_gl=1*1iopex7*_gcl_au*NTkwNDU5NTIzLjE3MzY0MzY2NTI.)
Open main navigation
Close main navigation
- [Blog](https://www.vigilance.ca/contact-us#formulaire)
- [Press releases](https://www.vigilance.ca/press-releases?_gl=1*k5efc9*_gcl_au*NTkwNDU5NTIzLjE3MzY0MzY2NTI.)
- [Vigilance.ca](https://www.vigilance.ca/home?_gl=1*1iopex7*_gcl_au*NTkwNDU5NTIzLjE3MzY0MzY2NTI.)
- [RxVigilance News](https://www.vigilance.ca/news?_gl=1*1iopex7*_gcl_au*NTkwNDU5NTIzLjE3MzY0MzY2NTI.)
- - [English](https://faq.vigilance.ca/en/rxvigilance-user-comments)
- [Français](https://faq.vigilance.ca/fr/rxvigilance-commentaires-utilisateurs)
English
Show submenu for translations
- [Can't find the answer you're looking for? Write to us.](https://faq.vigilance.ca/en/kb-tickets/new)
- Contact us
Contact us
How can we help you ?
- There are no suggestions because the search field is empty.
1. [FAQ](https://faq.vigilance.ca/en)
2. [RxVigilance](https://faq.vigilance.ca/en/rxvigilance)
# Can I share a recommendation or comment regarding clinical information about RxVigilance?
## Of course!
Our dedicated teams always greatly appreciate receiving feedback from users.
For general queries or recommendations, please send an e-mail to [info@vigilance.ca](mailto:info@vigilance.ca) or fill in the form on [https://www.vigilance.ca/contact-us](https://www.vigilance.ca/contact-us).
For questions or recommendations relating to the clinical content of our applications, please send an e-mail to [professionalinfo@vigilance.ca](mailto:professionalinfo@vigilance.ca) or complete the form available at [https://www.vigilance.ca/contact-us](https://www.vigilance.ca/contact-us).
You can also reach us by telephone at 450-582-3917 or 1-844-582-3917.
- [Online Store](https://faq.vigilance.ca/en/online-store)
- [Emails subscriptions](https://faq.vigilance.ca/en/emails-subscriptions)
- [RxVigilance](https://faq.vigilance.ca/en/rxvigilance)
- [Mobile experience](https://faq.vigilance.ca/en/mobile-experience)
- [RxConsultAction](https://faq.vigilance.ca/en/rxconsultaction)
- [RxPhotos](https://faq.vigilance.ca/en/rxphotos)
- [Blog](https://www.vigilance.ca/contact-us#formulaire)
- [Press releases](https://www.vigilance.ca/press-releases?_gl=1*k5efc9*_gcl_au*NTkwNDU5NTIzLjE3MzY0MzY2NTI.)
- [Vigilance.ca](https://www.vigilance.ca/home?_gl=1*1iopex7*_gcl_au*NTkwNDU5NTIzLjE3MzY0MzY2NTI.)
- [RxVigilance News](https://www.vigilance.ca/news?_gl=1*1iopex7*_gcl_au*NTkwNDU5NTIzLjE3MzY0MzY2NTI.)
[](http://vigilance.ca)
Copyright © 2026, Vigilance Santé inc.